Application and mechanism of WU Zhi-kui’s theory of “benefiting marrow and generating blood” in the treatment of Mediterranean anemia

GU Ke-bo; CHENG Yan-ling; SUN Yu-wen; HE Li-li; WU Zhi-kui

doi:10.16025/j.1674-1307.2021.04.013

您当前的位置：

首页 >

文章列表页 >

Application and mechanism of WU Zhi-kui’s theory of “benefiting marrow and generating blood” in the treatment of Mediterranean anemia

更新时间：2023-04-10

- Application and mechanism of WU Zhi-kui’s theory of “benefiting marrow and generating blood” in the treatment of Mediterranean anemia
- Beijing Journal of Traditional Chinese Medicine Vol. 40, Issue 4, Pages: 386-388(2021)
- 作者机构：
  
  1. 中国中医科学院广安门医院血液科
- 作者简介：
- 基金信息：
- DOI：10.16025/j.1674-1307.2021.04.013
  CLC：
扫描看全文
[1]顾恪波,程艳玲,孙玉雯,何立丽,吴志奎.吴志奎“益髓生血”理论治疗地中海贫血应用及机制[J].北京中医药,2021,40(04):386-388.

GU Ke-bo, CHENG Yan-ling, SUN Yu-wen, et al. Application and mechanism of WU Zhi-kui’s theory of “benefiting marrow and generating blood” in the treatment of Mediterranean anemia. [J]. Beijing Journal of Traditional Chinese Medicine 40(4):386-388(2021)
[1]顾恪波,程艳玲,孙玉雯,何立丽,吴志奎.吴志奎“益髓生血”理论治疗地中海贫血应用及机制[J].北京中医药,2021,40(04):386-388. DOI： 10.16025/j.1674-1307.2021.04.013.

GU Ke-bo, CHENG Yan-ling, SUN Yu-wen, et al. Application and mechanism of WU Zhi-kui’s theory of “benefiting marrow and generating blood” in the treatment of Mediterranean anemia. [J]. Beijing Journal of Traditional Chinese Medicine 40(4):386-388(2021) DOI： 10.16025/j.1674-1307.2021.04.013.

摘要

地中海贫血是单基因遗传病,发病率高、危害性大、致残率高,至今尚无特效疗法。中国中医科学院广安门医院吴志奎教授根据中医"肾藏精、生髓"及"精血同源"理论结合现代医学研究,提出"肾藏精"→"精生髓"→"髓生血"理论,并始终坚持运用"补肾益髓生血"法治疗地中海贫血。研究证实益髓生血颗粒可通过改善患者造血功能、减轻红细胞损伤与破坏等发挥治疗作用,可减轻患者贫血症状,提高生活质量并延长寿命。

Abstract

关键词

吴志奎地中海贫血遗传病溶血性贫血益髓生血

Keywords

吴志奎地中海贫血遗传病溶血性贫血益髓生血

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

No data

Related Author

No data

Related Institution

No data

⁰